Precigen Inc.
World Rank (Jan-05-2024)
15,259
Market Cap (Jan-05-2024)
0.326 Billion USD
World Rank (Jul-30-2023)
15,121
Market Cap (Jul-30-2023)
0.341 Billion USD
World Rank (Dec-25-2022)
15,801
Market Cap (Dec-25-2022)
0.296 Billion USD
World Rank (Jan-07-2022)
11,639
Market Cap (Jan-07-2022)
0.67 Billion USD
Annual Revenue in USD
103 Million USD
Annual Net Income in USD
-92 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Company Profile
Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in immuno-oncology, autoimmune disorders and infectious diseases. The company annual revenue is 103 million USD as on 2020. The headquarters is in USA.
Company Website